Mannatech Inc (NASDAQ:MTEX) Institutional Investors Sentiment

September 16, 2018 - By Mary Gaskins

Mannatech, Incorporated (NASDAQ:MTEX) Logo

Sentiment for Mannatech Inc (NASDAQ:MTEX)

Mannatech Inc (NASDAQ:MTEX) institutional sentiment decreased to 1.29 in Q2 2018. Its down -0.21, from 1.5 in 2018Q1. The ratio has worsened, as 9 funds opened new or increased stock positions, while 7 decreased and sold stakes in Mannatech Inc. The funds in our partner’s database now possess: 548,157 shares, down from 583,686 shares in 2018Q1. Also, the number of funds holding Mannatech Inc in their top 10 stock positions was flat from 0 to 0 for the same number . Sold All: 2 Reduced: 5 Increased: 4 New Position: 5.

Mannatech, Incorporated operates as a wellness solution provider. The company has market cap of $49.85 million. It develops and sells nutritional supplements, topical, skin care and anti-aging products, and weight-management products. It currently has negative earnings. The firm markets its products through network marketing channel in the Americas, Europe/the Middle East/Africa, and the Asia/Pacific.

The stock increased 2.98% or $0.6 during the last trading session, reaching $20.75. About 10,889 shares traded or 99.21% up from the average. Mannatech, Incorporated (NASDAQ:MTEX) has risen 43.06% since September 16, 2017 and is uptrending. It has outperformed by 27.44% the S&P500.

Bridgeway Capital Management Inc holds 0.01% of its portfolio in Mannatech, Incorporated for 61,509 shares. Spark Investment Management Llc owns 11,900 shares or 0.01% of their US portfolio. Moreover, Acadian Asset Management Llc has 0% invested in the company for 43,743 shares. The North Carolina-based Bank Of America Corp De has invested 0% in the stock. Blackrock Inc., a New York-based fund reported 78,347 shares.

Since January 1, 0001, it had 2 insider purchases, and 0 insider sales for $34,424 activity.

Mannatech, Incorporated (NASDAQ:MTEX) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.